Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.
2.

Activation of the c-Met receptor complex in fibroblasts drives invasive cell behavior by signaling through transcription factor STAT3.

Cramer A, Kleiner S, Westermann M, Meissner A, Lange A, Friedrich K.

J Cell Biochem. 2005 Jul 1;95(4):805-16.

PMID:
15838885
3.

Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.

Ling X, Arlinghaus RB.

Cancer Res. 2005 Apr 1;65(7):2532-6. Erratum in: Cancer Res. 2005 Jun 1;65(11):4969.

4.
5.
6.

Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis.

Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F, Sawaya R, Huang S.

Oncogene. 2004 Apr 29;23(20):3550-60.

PMID:
15116091
7.

Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity.

Turkson J, Kim JS, Zhang S, Yuan J, Huang M, Glenn M, Haura E, Sebti S, Hamilton AD, Jove R.

Mol Cancer Ther. 2004 Mar;3(3):261-9.

8.

Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.

Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ.

Clin Cancer Res. 2005 Sep 1;11(17):6333-41.

9.

Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours.

Lai R, Rassidakis GZ, Medeiros LJ, Leventaki V, Keating M, McDonnell TJ.

J Pathol. 2003 Jan;199(1):84-9.

PMID:
12474230
10.

A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.

Nishimoto A, Yu Y, Lu Z, Mao X, Ren Z, Watowich SS, Mills GB, Liao WS, Chen X, Bast RC Jr, Luo RZ.

Cancer Res. 2005 Aug 1;65(15):6701-10.

11.

Structural requirements for signal transducer and activator of transcription 3 binding to phosphotyrosine ligands containing the YXXQ motif.

Shao H, Xu X, Mastrangelo MA, Jing N, Cook RG, Legge GB, Tweardy DJ.

J Biol Chem. 2004 Apr 30;279(18):18967-73. Epub 2004 Feb 13.

12.

Interferon induces the interaction of prothymosin-alpha with STAT3 and results in the nuclear translocation of the complex.

Yang CH, Murti A, Baker SJ, Frangou-Lazaridis M, Vartapetian AB, Murti KG, Pfeffer LM.

Exp Cell Res. 2004 Aug 1;298(1):197-206.

PMID:
15242774
13.

PKCdelta plays opposite roles in growth mediated by wild-type Kit and an oncogenic Kit mutant.

Jelacic T, Linnekin D.

Blood. 2005 Mar 1;105(5):1923-9. Epub 2004 Nov 12.

14.

A model for GFR alpha 4 function and a potential modifying role in multiple endocrine neoplasia 2.

Vanhorne JB, Andrew SD, Harrison KJ, Taylor SA, Thomas B, McDonald TJ, Ainsworth PJ, Mulligan LM.

Oncogene. 2005 Feb 3;24(6):1091-7.

PMID:
15592530
15.

Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2B.

Gujral TS, Singh VK, Jia Z, Mulligan LM.

Cancer Res. 2006 Nov 15;66(22):10741-9.

16.
17.

Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.

Xu H, Washington S, Verderame MF, Manni A.

Breast Cancer Res Treat. 2008 Nov;112(2):255-61. Epub 2007 Dec 21.

PMID:
18097746
18.

c-Jun N-terminal kinase (JNK) positively regulates NFATc2 transactivation through phosphorylation within the N-terminal regulatory domain.

Ortega-Pérez I, Cano E, Were F, Villar M, Vázquez J, Redondo JM.

J Biol Chem. 2005 May 27;280(21):20867-78. Epub 2005 Mar 2.

19.

Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells.

Mizutani T, Fukushi S, Murakami M, Hirano T, Saijo M, Kurane I, Morikawa S.

FEBS Lett. 2004 Nov 5;577(1-2):187-92.

20.

Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.

Aziz MH, Manoharan HT, Church DR, Dreckschmidt NE, Zhong W, Oberley TD, Wilding G, Verma AK.

Cancer Res. 2007 Sep 15;67(18):8828-38.

Supplemental Content

Support Center